Physician

Ryan L Haulk, M.D.

According to 2025 Medicare claims, Ryan Haulk, M.D. (NPI: 1366573180) practices nephrology in the Elizabethtown, KY market, with the plurality of this provider's patient population coming from Hardin, KY. This provider's primary affiliated billing organization is NEPHROLOGY ASSOCIATES OF KENTUCKIANA PSC (NPI: 1730161753; TIN: 611141697) and primary practice location at 42718-7638.

Haulk's data goes back to 2015 and runs through 2024. For example, in 2024, this provider had 929 traditional Medicare patients, billed 3,341 HCPCS/CPT codes, and received $229,018 in Medicare payments. The top billing code was 99204 (New patient office or other outpatient visit with moderate level of medical decision making, if using time, 45 minutes or more). Part D data shows 1,831 prescription claims across 384 beneficiaries totaling $438,669 in drug costs, led by Farxiga (Dapagliflozin Propanediol). 2023 DME data shows 36 claims. Open Payments data shows 5 records totaling $95. You can download detailed data with all billing codes (2015-2024). For more recent data, please contact us.

Over the past 10 years, this provider's Medicare Part B carrier billing has changed little. Concurrently, Part D prescription costs have moved up and down with repeated peaks and valleys, starting at $291,066 and ending at $438,669. In contrast, DME billing represents a smaller volume and changed little.

Part B Carrier Billing Trend

Medicare payment trend, with N of patients and claim lines in the table.

Year	Patients	Clm Lines	Payment
2015	917	3,053	$266,422
2016	973	2,973	$283,700
2017	1,052	3,041	$279,697
2018	1,058	2,880	$274,175
2019	995	3,109	$317,148
2020	941	2,974	$294,117
2021	849	2,382	$264,190
2022	841	2,285	$228,549
2023	836	2,159	$213,761
2024	929	3,341	$229,018

Part D Events Trend

Drug cost trend, with N of patients and prescription claims in the table.

Year	Patients	Claims	Drug Cost
2015	234	1,941	$291,066
2016	314	2,574	$517,627
2017	336	2,642	$522,767
2018	327	2,377	$299,405
2019	356	2,256	$239,019
2020	326	2,130	$254,730
2021	339	2,211	$274,658
2022	322	1,548	$333,832
2023	348	1,774	$451,803
2024	384	1,831	$438,669

DME Billing Trend

Medicare payment trend, with N of patients and DME claim records in the table.

Year	Patients	Claims	Payment
2015	N/R	23	$1,819
2016	N/R	64	$9,228
2017	N/R	72	$10,886
2018	N/R	48	$2,114
2019	N/R	77	$5,895
2020	N/R	117	$6,205
2021	N/R	136	$6,346
2022	N/R	58	$1,470
2023	N/R	36	$1,405
2024	N/R	N/R	N/R

* / # = suppressed by CMS; 0 = reported zero; N/R = not reported or blank.

Top 5 Part B carrier billing codes in 2024

By total payments.

Code	Description	Patients	Clm Lines	Total Payment
99204	New patient office or other outpatient visit with moderate level of medical decision making, if using time, 45 minutes or more	106	106	$104
99214	Established patient office or other outpatient visit with moderate level of decision making, if using time, 30 minutes or more	503	625	$61
99232	Subsequent hospital care with moderate levelof medical decision making, if using time, at least 35 minutes	212	670	$58
99490	Chronic care management services, first 20 minutes of clinical staff time directed by health care professional, per calendar month	106	443	$37
G2211	Visit complexity inherent to evaluation and management associated with medical care services that serve as the continuing focal point for all needed health care services and/or with medical care services that are part of ongoing care related to a patient's	582	726	$12

Top 5 Part D drugs in 2024

By total drug costs.

Drug	Generic	Claims	Total Day Supply	Total Drug Cost
Farxiga	Dapagliflozin Propanediol	297	12,519	$225,261
Jardiance	Empagliflozin	21	1,350	$25,028
Auryxia	Ferric Citrate	12	480	$22,699
Sevelamer Carbonate	Sevelamer Carbonate	65	3,381	$11,669
Lokelma	Sodium Zirconium Cyclosilicate	12	536	$11,025

Top 5 DME services in 2024

No connected or detailed DME service-level records for 2024.

Open Payments Summary in 2024

Category	Definition	Records	Total Reported Amount	Top Related Entity
General Payments	Reported payment or transfer-of-value amount.	5	$95	Aurinia Pharma U.S., Inc.
Research Payments	Reported research-related payment or transfer-of-value amount.	0	$0	N/R
Ownership / Investment Interests	Reported value of ownership or investment interests.	0	$0	N/R

Explore More Providers

FAQ

What Medicare data is available for Ryan L. Haulk, M.D.?

Tedicare shows public-source Medicare data for Ryan L. Haulk, M.D. (NPI 1366573180), including provider identity, specialty, market context, Medicare Part B activity, Part D prescribing, DME records, Open Payments where available, billing organization details, and ACO affiliation signals where available. Profile data covers 2015-2024, with current attribution based on 2025 claims where available.

Does Ryan L. Haulk, M.D. have ACO affiliation data?

No ACO affiliation record is shown in the available Tedicare data for this profile.

What billing organization is linked to Ryan L. Haulk, M.D.?

Ryan L. Haulk, M.D. is linked to NEPHROLOGY ASSOCIATES OF KENTUCKIANA PSC (billing NPI 1730161753) in the available physician profile data.

Does Ryan L. Haulk, M.D. have Open Payments data?

Ryan L. Haulk, M.D. has 5 connected Open Payments records in the available 2024 summary data.

Can I download physician-level Medicare data from Tedicare?

Yes. Tedicare provides sample physician export data and paid custom physician data exports for research, planning, outreach, and market analysis. Exports can include physician profile fields, market and specialty context, billing organization details, ACO affiliation signals where available, and Medicare utilization data.